top of page

Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Unique. Not rare.

One in 2,000 people—about 52 million in Latin America—live with one of 7,000 rare diseases identified by the WHO. But behind these numbers are real people, each with unique stories and challenges. At SANAS, we focus on access and support, beyond prevalence or location.

But the numbers rarely tell the story.

Limited, often unreliable data exclude entire communities without access to proper diagnostics. From neurological disorders to genetic conditions, rare diseases defy labels, affecting people from all walks of life.

Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Wilson's Disease, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

ALS/Lou Gehrig's Disease, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Inborn Errors of Metabolism, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Myasthenia Gravis, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

MS/Multiple Sclerosis, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Cystic Fibrosis, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Pulmonary Arterial Hypertension, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Idiopathic Pulmonary Fibrosis, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Duchenne Muscular Dystrophy, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Cerebral Palsy, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Leukemia, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Glioblastoma, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Bladder Cancer, Access medications, Import non-register medications, Name-patient sales, Medications not available locally, Latin America medication import, Managed Access Programs, Access to orphan drugs, Global pharmaceutical access, Rare diseases, LATAM access to medications, Sanas, Drugs, Medications, Pharmaceutical, laboratory

Partner with SANAS
today and help us heal communities by improving the quality
of life of patients and their families throughout Latin America, right at home. Let's dare redefine rare disease care.

bottom of page